Molecular docking of the highly hypolipidemic agent α-asarone with the catalytic portion of HMG-CoA reductase

Docking experiments using a number of published crystal structures of HMG-CoA reductase with the potent hypocholesterolemic agent α-asarone are described. The docking results will be valuable for the structure-based design novel hypolipidemic agents.